Structure Therapeutics Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

2.14B USD

Revenue Chart

Revenue History

Fiscal Year End	Change	Growth
Dec 31, 2023	-	-
Dec 31, 2022	-	-
Dec 31, 2021	-	-
Dec 31, 2020	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

GPCR News

6 weeks ago - Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional American Depositary Shares - GlobeNewsWire
6 weeks ago - Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering - GlobeNewsWire
6 weeks ago - Structure Therapeutics Announces Proposed Public Offering of American Depositary Shares and Pre-Funded Warrants - GlobeNewsWire
6 weeks ago - Structure Therapeutics reports promising weight-loss drug data - Invezz
7 weeks ago - Structure Therapeutics' stock jumps on weight-loss-pill trial results - Market Watch
7 weeks ago - Structure Therapeutics Reports Positive Topline Data from its Phase 2a Obesity Study and Capsule to Tablet PK Study for its Oral Non-Peptide Small Molecule GLP-1 Receptor Agonist GSBR-1290 - GlobeNewsWire
2 months ago - Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance - CNBC
3 months ago - Big pharma is looking to fatten profits with buyouts of weight-loss drug companies. Here are 4 candidates. - Market Watch

More News